Boehringer Ingelheim has opened a €60m ($66.8m) research building in Vienna, Austria, as the company looks to double down in the oncology therapeutics space. The building is named after Angelika ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...

Greater awareness of – and engagement around – the Boehringer Ingelheim brand. Facebook friends and family of everyone who tries out the game will potentially be exposed to it, while media ...

October 1, 2024–Celebrate the magnificence of horses during Horse Week 2024, an online film festival proudly presented by ...

German drugmaker Boehringer Ingelheim has its first regulatory approval ... The FDA has cleared the IL-36 receptor inhibitor under the Spevigo brand name to treat the devastating eruptions of ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

German family-owned pharma major Boehringer Ingelheim and USA-based Circle Pharma (have entered into a research collaboration and license agreement with the shared goal to develop a first-in-class ...

In the future, around one third of the new products at Boehringer Ingelheim will come from oncology.” Newest technologies and laboratories allow scientists to faster achieve their goal to develop ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...